Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
Published version of a preprint
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Pharmacoepidemiologic studies provide evidence that use of metformin, a drug commonly prescribed for type II diabetes, is associated with a substantial reduction in cancer risk. Experimental models show that metformin inhibits the growth of certain neoplasms by cell autonomous mechanisms such as activation of AMP kinase with secondary inhibition of protein synthesis or by an indirect mechanism involving reduction in gluconeogenesis leading to a decline in insulin levels and reduced proliferation of insulin-responsive cancers. Here, we show that metformin attenuates paraquat-induced elevations in reactive oxygen species (ROS), and related DNA damage and mutations, but has no effect on similar changes induced by H(2)0(2), indicating a reduction in endogenous ROS production. Importantly, metformin also inhibited Ras-induced ROS production and DNA damage. Our results reveal previously unrecognized inhibitory effects of metformin on ROS production and somatic cell mutation, providing a novel mechanism for the reduction in cancer risk reported to be associated with exposure to this drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and reduction in DNA damage (Algire et al., 2012).”
From Metformin as a tool to target aging (2016) · cites this paper as Algire et al., 2012
In the citing paper
“In mouse embryonic fibroblasts (MEFs), metformin is shown to reduce paraquat-associated endogenous ROS levels and associated DNA damage by preventing ROS toxicity”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Algire et al. 2012
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“As complex I is an important source of ROS (24), we studied”
BackgroundAMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · cited 1×
“There is also evidence for direct actions of metformin on neoplastic cells (16, 17, 19) secondary to various AMPKdependent antiproliferative effects such as inhibition of mTOR (22), or, for those neoplasms that have impaired ability to survive under conditions of energy stress, cell death related to ATP deficiency (18…”
BackgroundRequirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520 · cited 1×
“Metformin blocks paraquat-induced and antimycininduced, but not H2O2-induced, ERK activation ROS increases ERK signaling (26).”
BackgroundGenomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397 · cited 1×
“and associated DNA damage is important from the perspective that genome instability is an "enabling characteristic" for neoplasia (35) that can be a consequence of oncogene activation (36).”
BackgroundOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 6×
“NADH oxidation by complex I leads to accumulation of NADH (2), a phenomenon that we confirmed in MEFs treated with metformin (Supplementary Fig.”
BackgroundInfluentialInsulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Self-citationThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 1×
“In type II diabetes, metformin action in the liver results in inhibition of gluconeogenesis, reducing blood glucose concentration (4, 5), and secondarily”
BackgroundThe LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“The DNA damage response constitutes a barrier for tumor progression (32), and tumors arise when these barriers are inactivated by genetic or epigenetic mechanisms.”
Background
Cited by
Metformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445
Self-citationMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Self-citationMetformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
“Previous reports have shown that metformin does not substantially increase H2O2 production in isolated liver mitochondria and that metformin diminishes mitochondrial H2O2 production in response to paraquat, which induces mitochondrial ROS production (Batandier et al., 2006; Algire et al., 2012).”
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
“…oxygen species (ROS) (Batandier et al., 2006; Bridges et al., 2014; Zheng et al., 2012), activation of AMP-activated kinase (AMPK) (Cho et al., 2015; Duca et al., 2015; Foretz et al., 2010; Lien et al., 2014; Lu et al., 2015; Zheng et al., 2012), and reduction in DNA damage (Algire et al., 2012).”
Metadata
- Authors
- Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N.
- Affiliations
- Inserm (FR)
- Authors' Affiliations: 1Division of Experimental Medicine, McGill University and Segal Cancer Centre of Jewish General Hospital; 2Département de Biochimie, Université de Montréal, Montréal, Québec, Canada; 3INSERM, U1016, Institut Cochin, Paris France; 4CNRS UMR8104, Paris, France; and 5Université Paris Descartes, Sorbonne Paris Cité, Paris France
- Venue
- Cancer Prevention Research
- Published
- 2012-04-01
- Volume
- 5
- Issue
- 4
- Pages
- 536-543
- ISSN
- 1940-6207 (ISSN-L)
- 1940-6215
- OpenAlex
- W2140204893
- Cited by
- 372
- References
- 40
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 21 · 2023: 42 · 2022: 31 · 2021: 34 · 2020: 41 · 2019: 25 · 2018: 22 · 2017: 29 · 2016: 22 · 2015: 15 · 2014: 25 · 2013: 19 · 2012: 17
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Prevention Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- metformin, reactive oxygen species, DNA damage, somatic mutations, paraquat, hydrogen peroxide, Ras, chemoprevention, type 2 diabetes, AMP kinase, insulin
- MeSH terms
- Adenylate Kinase, Animals, Cell Line, Diabetes Mellitus, Type 2, DNA Damage, Enzyme-Linked Immunosorbent Assay, Epidermal Growth Factor, Fibroblasts, Flow Cytometry, Humans, Hydrogen Peroxide, Hypoglycemic Agents, Insulin, Male, Metformin, Mice, Inbred C57BL, Microscopy, Fluorescence, Mutation, NADP, Mutagenesis, Reactive Oxygen Species, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. https://app.cochat.ai/papers/10.1158/1940-6207.capr-11-0536
- The paper
- Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N. (2012). Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. Cancer Prevention Research. https://doi.org/10.1158/1940-6207.capr-11-0536
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.